QS Investors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-15,675
Closed -$617K – 1270
2020
Q3
$617K Sell
15,675
-68,291
-81% -$2.21M 0.01% 605
2020
Q2
$2.65M Buy
83,966
+2,800
+3% +$105K 0.04% 385
2020
Q1
$2.86M Sell
81,166
-3,064
-4% -$129K 0.05% 310
2019
Q4
$4.09M Sell
84,230
-1,588
-2% -$72.3K 0.04% 340
2019
Q3
$4.08M Hold
85,818
– – 0.04% 331
2019
Q2
$3.69M Sell
85,818
-2,000
-2% -$77.6K 0.04% 364
2019
Q1
$3.4M Hold
87,818
– – 0.04% 388
2018
Q4
$2.5M Hold
87,818
– – 0.03% 451
2018
Q3
$3.44M Buy
87,818
+42
+0% +$1.55K 0.03% 411
2018
Q2
$2.84M Buy
87,776
+10
+0% +$275 0.03% 485
2018
Q1
$1.93M Sell
87,766
-5,202
-6% -$125K 0.02% 595
2017
Q4
$2.2M Sell
92,968
-4,610
-5% -$116K 0.02% 581
2017
Q3
$2.75M Sell
97,578
-1,970
-2% -$59.9K 0.02% 500
2017
Q2
$3.21M Buy
99,548
+11,287
+13% +$344K 0.03% 441
2017
Q1
$2.5M Buy
88,261
+218
+0.2% +$5.79K 0.02% 532
2016
Q4
$2.13M Buy
88,043
+13,003
+17% +$319K 0.02% 600
2016
Q3
$1.78M Buy
+75,040
New +$1.64M 0.01% 668

Other funds holding CSII

QS Investors's CSII Position: Q4 2020 in Review

QS Investors sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2020, closing a stake of 15,675 shares — an estimated $617K sold.

QS Investors first reported a position in CSII in Q3 2016 and held it in 17 quarters. The position peaked at $4.09M in Q4 2019. 183 funds tracked by Wall St. Rank hold CSII as of Q4 2020.

  • QS Investors reported no remaining Cardiovascular Systems, Inc. position as of Q4 2020 after selling out during the quarter.
  • QS Investors sold 15,675 Cardiovascular Systems, Inc. shares in Q4 2020, an estimated $617K.
  • QS Investors first reported a position in Cardiovascular Systems, Inc. in Q3 2016 and held it in 17 quarters.
  • QS Investors's Cardiovascular Systems, Inc. position peaked at $4.09M in Q4 2019.
  • 183 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2020.

Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.